Since its inception in 1992 by Dr. Johannes Gassmueller, bioskin® has been recognized as a valuable partner for dermatological product development. Starting as a small Contract Research Organization (CRO) specialized in conducting early phase safety and efficacy trials in our clinical unit in Hamburg, bioskin® has grown into a full-service CRO offering all core services for management of Phase I-IV drug trials and claim support/safety studies as well as strategic consulting and regulatory services. bioskin® is privately-owned.
Headquartered in Hamburg, Germany, bioskin® added a second clinical unit in Germany’s capital and largest city, Berlin, in 2002 to expand recruitment capabilities for both patients with dermatological conditions and healthy volunteers for early phase studies. For national multicenter studies, we have built an investigator database which facilitates recruitment of investigators throughout Germany. Further, bioskin® has established a global network of preferred partners for the conduct of multinational studies in all dermatological indications. In addition to Cu-Tech, LLC, our US partner in the The International Dermatology Alliance for Clinical Research since 2009, we have partners for site management and monitoring throughout Europe, Ukraine, Russia, India, Latin America and South Africa.
Since 2013 bioskin® has a US office located in California where our Director of Global Regulatory and Clinical Affairs is based.